Mivavotinib
Showing 1 - 1 of 1
Non-GCB/ABC DLBCL, With and Without MyD88 and/or CD79B Mutations Trial in Cleveland, Toledo (Mivavotinib)
Recruiting
- Non-GCB/ABC Diffuse Large B-Cell Lymphoma
- With and Without MyD88 and/or CD79B Mutations
- Mivavotinib
-
Evanston, Illinois
- +6 more
Dec 12, 2022